Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
Blood-Brain Barrier Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Brain Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Ferrosoferric Oxide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2021

Opening of the Blood-Brain Barrier to Antitumor Agents

Neuwelt, E.

National Institutes of Health

5/4/163/31/21

Project: Research projectResearch Project

Blood-Brain Barrier
Antineoplastic Agents
Drug Therapy
Cisplatin
Neoplasms

Two Compartment Models to Improve Brain Tumor Therapy

Neuwelt, E.

National Institutes of Health

8/15/952/28/19

Project: Research projectResearch Project

Brain Neoplasms
Lymphoma
Central Nervous System
Blood-Brain Barrier
Immunotherapy

Delivery issues in lung cancer CNS metastases

Neuwelt, E.

National Institutes of Health

4/1/123/31/16

Project: Research projectNon-HHS Research Projects

Lung Neoplasms
Neoplasm Metastasis
temozolomide
Brain Neoplasms
Blood Volume
Nanoparticles
Magnetic Resonance Imaging
Inflammation
Ferrosoferric Oxide
Blood Vessels

Research Output 1971 2018

  • 13421 Citations
  • 60 h-Index
  • 303 Article
  • 8 Chapter
  • 2 Review article
  • 1 Conference contribution

Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care

Varallyay, C. G., Nesbit, E., Horvath, A., Varallyay, P., Fu, R., Gahramanov, S., Muldoon, L. L., Li, X., Rooney, W. D. & Neuwelt, E. A. Jan 1 2018 (Accepted/In press) In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalArticle

Ferrosoferric Oxide
Standard of Care
Contrast Media
Perfusion
Noise
1 Citations

Comprehensive review of the ThinkFirst injury prevention programs: A 30-Year success story for organized neurosurgery

Youngers, E. H., Zundel, K., Gerhardstein, D., Martínez, M., Bertrán, C., Proctor, M. R., Spatola, M. A. & Neuwelt, E. A. Sep 1 2017 In : Clinical Neurosurgery. 81, 3, p. 416-421 6 p.

Research output: Contribution to journalArticle

Neurosurgery
Wounds and Injuries
Young Adult
Nonprofit Organizations
Program Evaluation
7 Citations

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging

Toth, G. B. , Varallyay, C. G. , Horvath, A. , Bashir, M. R. , Choyke, P. L. , Daldrup-Link, H. E. , Dosa, E. , Finn, J. P. , Gahramanov, S. , Harisinghani, M. , Macdougall, I. , Neuwelt, A. , Vasanawala, S. S. , Ambady, P. , Barajas, R. , Cetas, J. S. , Ciporen, J. , DeLoughery, T. J. , Doolittle, N. D. , Fu, R. & 13 others Grinstead, J., Guimaraes, A. R., Hamilton, B. E., Li, X., McConnell, H. L., Muldoon, L. L., Nesbit, G., Netto, J. P., Petterson, D., Rooney, W. D., Schwartz, D., Szidonya, L. & Neuwelt, E. A. Jul 1 2017 In : Kidney International. 92, 1, p. 47-66 20 p.

Research output: Contribution to journalReview article

Ferrosoferric Oxide
Magnetic Resonance Imaging
Contrast Media
Central Nervous System
Atlases
2 Citations

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency

Dósa, E., Heltai, K., Radovits, T., Molnár, G., Kapocsi, J., Merkely, B., Fu, R., Doolittle, N. D., Tóth, G. B., Urdang, Z. & Neuwelt, E. A. Oct 3 2017 In : Fluids and Barriers of the CNS. 14, 1, 26

Research output: Contribution to journalArticle

Acetylcysteine
Cisplatin
Renal Insufficiency
Maximum Tolerated Dose
Auditory Hair Cells
9 Citations

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

Freyer, D. R., Chen, L., Krailo, M. D., Knight, K., Villaluna, D., Bliss, B., Pollock, B. H., Ramdas, J., Lange, B., Van Hoff, D., VanSoelen, M. L., Wiernikowski, J., Neuwelt, E. A. & Sung, L. Jan 1 2017 In : The Lancet Oncology. 18, 1, p. 63-74 12 p.

Research output: Contribution to journalArticle

Hearing Loss
Cisplatin
Neoplasms
Audiometry
Control Groups